Riskpilot← Back to searchSign inGet full accessTandhälsovården i Gävle AB
ABActiveOrg 5592670052Lantmäterigatan 2 ADental practice care activities · NACE 8623Est. 202020 employees
Revenue 2025
SEK 29,8M
+28% vs 2024
EBITDA margin
18.8%
+19% vs 2024
Equity ratio
63.4%
Financial strength
Net profit 2025
SEK 3,6M
+21% vs 2024
| Revenue | SEK 29,8M | +28% |
| EBITDA | SEK 5,6M | +19% |
| Net profit | SEK 3,6M | +21% |
| Total assets | SEK 8,6M | +7% |
| Equity | SEK 5,4M | +11% |
| Employees | 20 | — |
Legal name
Tandhälsovården i Gävle AB
Org number
5592670052
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
13 augusti 2020
Share capital
SEK 25 000
Employees
20 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva tandläkarverksamhet, konsultation inom tandvård, förvalta värdepapper samt därmed förenlig verksamhet.
Address
Lantmäterigatan 2 A
Phone
+4626125000
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 10 342 | 15 216 | 21 603 | 23 236 | 29 785 |
| Staff expenses | — | −5 868 | −9 246 | −9 747 | −13 494 |
| EBITDA | 2 975 | 4 105 | 3 793 | 4 690 | 5 597 |
| Depreciation & amort. | −242 | −431 | −751 | −870 | −1 306 |
| EBIT | 2 733 | 3 675 | 3 042 | 3 820 | 4 291 |
| Net financials | — | −1 | −17 | −12 | 189 |
| Profit before tax | 2 233 | 3 174 | 4 024 | 3 808 | 4 481 |
| Tax | −489 | −658 | −869 | −859 | −921 |
| Net profit | 1 744 | 2 516 | 3 155 | 2 949 | 3 560 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 745 | 8 274 | 7 583 | 8 039 | 8 594 |
| Equity | 1 769 | 3 284 | 4 940 | 4 889 | 5 449 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 1 477 | 3 990 | 2 643 | 3 150 | 3 145 |
| Total debt | 1 477 | 3 990 | 2 643 | 3 150 | 3 145 |
EBITDA margin
18.8%
This company
15.8%
Market median
+19% vs market
20212025
Equity ratio
63.4%
This company
38.2%
Market median
+66% vs market
20212025
Return on equity
65.3%
This company
18.4%
Market median
+255% vs market
20212025
Net profit margin
12.0%
This company
8.1%
Market median
+48% vs market
20212025
Asset turnover
3.47×
This company
1.12×
Market median
+210% vs market
20212025
Debt / equity
0.58×
This company
0.62×
Market median
+6% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-08-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AL | Audit | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
| Deputy Board Member | 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Celstedt Holding AB
Tandhälsovården i Gävle AB Board members of Tandhälsovården i Gävle AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alexander Lars Rolf Ekqvist | Audit | 0 companies |
| Hans Mattias Lundblad | Deputy Board Member | 0 companies |
| Emma Kristina Malmström Cehlstedt | Board of Directors | 0 companies |
| Erik Magnus Malmström | Deputy Board Member | 0 companies |
| Isak Magnus Malmström | Deputy Board Member | 0 companies |